Healthcare -
Biotechnology - NASDAQ - US
$ 5.6
0 %
$ 259 M
Market Cap
-1.96
P/E
FDMT - CHANGE IN WORKING CAPITAL
Change in Working Capital FDMT - 4D Molecular Therapeutics, Inc.
630 K
LAST VALUE
42.85%
2 YEAR CAGR
15.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR